Please assess the completion status of the following clinical trial:

Trial Title: Secretin Enhanced Multidetector CT Pancreatography for Evaluation of Known or Suspected Chronic Pancreatitis

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Males and females older than 18 years of age~* Is clinically indicated for contrast-enhanced MDCT of the pancreas~* Scheduled for MDCT and therapeutic or diagnostic ERCP for the assessment of chronic pancreatitis~* Has been fully informed and has personally signed and dated the Written Informed Consent and Health Insurance Portability Accountability Act (HIPAA) provisions~* Is a male, or is a female not of childbearing potential, or is a female of childbearing potential who is using effective contraception and has a negative urine pregnancy test on the same day, but prior to, study drug administration~* Is able and willing to complete all study procedures specified in the protocol~Exclusion Criteria:~* Has no clear written indication for contrast enhanced MDCT of the pancreas~* Has a history of hypersensitivity to iodine-containing compounds~* Has congestive cardiac failure (class III-IV in accordance with the classification of the New York Heart Association \[NYHA\])~* Presence of a pancreatic stent~* Is unable to comply with the study requirements including follow-up~* History of any clinically significant cardiac, endocrinologic, hematologic, hepatic, immunologic, metabolic, urologic, pulmonary, neurologic, dermatologic, psychiatric, renal, and/or other major disease which, in the opinion of the investigator, precludes study participation~* History of sensitivity to any of the ingredients in the study drug~* Pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Drug + MDCT

Based on this trial design, predict the completion outcome and termination type (if applicable).